Tohru Nakanishi graduated Faculty of Science, Tokyo University, and spent his scientific carrier in the Institute for Molecular and Cellular Biology, Osaka University, Virus Institute, Kyoto University, National Institute for Basic Biology, Okazaki, and Okayama University. His main achievements are the establishment of novel diagnostic system of hGH by using MAbs, cloning, and characterization of elongation facter-2 (EF-2) gene, characterization of expression of neurotrophins, and cloning and functional analysis of connective tissue growth factor (CTGF). He is now Professor and Chairman of molecular diagnosis, Shujitsu University School of Pharmacy, Okayama. His recent work towards postgenomic research include DNA chips and siRNAs targeting RA, stem cells, and AChR. He has found the novel possibility for treatment of RA by using siRNA targeting tetraspanin CD81. Besides his involvement in the research collaboration with Pasteur Institute, he plays an important role in the activity of Pasteur-Japan Association.
Biography Updated on 24 January 2012